| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.11. | Sysmex GAAP EPS of ¥29.47, revenue of ¥272.82B | 1 | Seeking Alpha | ||
| 10.11. | Sysmex Corporation H1 Profit Drops | 388 | AFX News | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) released earnings for first half that Dropped, from the same period last yearThe company's bottom line came in at JPY17.933 billion, or JPY29.47... ► Artikel lesen | |
| 09.11. | Saibogen PTE. LTD.: Hologen and Sysmex establish Saibogen, a joint venture using AI to turn routine blood test data into clinical intelligence | 432 | GlobeNewswire (Europe) | The joint venture will apply generative AI to the detailed hematology data in routine blood counts, aiming to give researchers and clinicians a richer view of each patient, with no new instruments,... ► Artikel lesen | |
| 09.09. | Sysmex Europe SE and Cytek Biosciences, Inc. Collaborate to Expand Access to Advanced Clinical Flow Cytometry | 925 | GlobeNewswire (Europe) | FREMONT, Calif., and HAMBURG, Germany, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sysmex Europe SE, a leader in diagnostic and healthcare solutions, and Cytek Biosciences, Inc. (Nasdaq: CTKB), a leader in spectral... ► Artikel lesen | |
| SYSMEX CORPORATION ADR Aktie jetzt für 0€ handeln | |||||
| 07.08. | Sysmex GAAP EPS of ¥14.17, revenue of ¥130.67B; updates FY 2027 outlook | 32 | Seeking Alpha | ||
| 07.08. | Sysmex Corporation Announces Increase In Q1 Profit | 1.019 | AFX News | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) revealed a profit for its first quarter that Increased, from the same period last yearThe company's bottom line totaled JPY8.691 billion, or JPY14.17... ► Artikel lesen | |
| 17.06. | VolitionRx partners with Sysmex to optimize Nu.Q NETs assay | 12 | Seeking Alpha | ||
| 17.06. | VolitionRx und Sysmex kooperieren bei der Entwicklung von Diagnosetests | 5 | Investing.com Deutsch | ||
| 17.06. | VolitionRx Limited: VolitionRx Announces Collaboration with Sysmex | 715 | PR Newswire | HENDERSON, Nev., June 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration... ► Artikel lesen | |
| 17.06. | EQS-News: Sysmex Europe SE: Sysmex führt die HISCL Plattform ein, die schnelle, skalierbare Analysen aus Blut für die Alzheimerkrankheit ermöglicht | 759 | EQS Group (DE) | EQS-News: Sysmex Europe SE
/ Schlagwort(e): Produkteinführung/Sonstiges
Sysmex führt die HISCL Plattform ein, die schnelle, skalierbare Analysen aus Blut für die Alzheimerkrankheit... ► Artikel lesen | |
| 17.06. | Sysmex Europe SE: Sysmex launches HISCL platform, enabling faster, scalable Alzheimer's blood testing | 904 | PR Newswire | HAMBURG, Germany, June 17, 2026 /PRNewswire/ -- Independent European studies presented at CTAD 2025 and ADPD2026 confirmed that the HISCL p-Tau217 RUO* and the HISCL Aß42/40 ratio are highly... ► Artikel lesen | |
| 14.05. | Sysmex FY Net Profit Declines | 724 | AFX News | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sysmex (6869.T) reported fiscal year profit attributable to owners of the parent of 35.5 billion yen, a decline of 33.9% from prior year. Operating profit... ► Artikel lesen | |
| 14.04. | Sysmex Europe eröffnet offiziell seinen neuen Campus in Hamburg und setzt damit neue Maßstäbe für zukunftsorientierte Arbeitsumgebungen | 1.014 | news aktuell | Hamburg (ots) - Sysmex Europe hat offiziell seinen neuen Bürocampus in Hamburg-Alsterdorf eröffnet und damit den Umzug seines EMEA-Hauptsitzes von Norderstedt in die Stadt abgeschlossen. Rund 780 Mitarbeiter... ► Artikel lesen | |
| 12.02. | Sysmex Corporation Bottom Line Drops In Nine Months | 968 | AFX News | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) announced a profit for nine months that Dropped, from the same period last yearThe company's earnings came in at JPY33.694 billion, or JPY54.05... ► Artikel lesen | |
| 05.02. | Fujirebio und Sysmex beginnen Vertriebskooperation für Demenz-Tests | 836 | Business Wire | Fujirebio Holdings, Inc. (Zentrale: Minato-ku, Tokio; President CEO: Goki Ishikawa; "Fujirebio"), eine konsolidierte Tochtergesellschaft der H.U. Group Holdings, Inc. (Zentrale: Minato-ku, Tokio;... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| RESMED | 215,40 | -0,23 % | RESMED INC: Form 8-K | ||
| CARDINAL HEALTH | 250,50 | +0,93 % | Wells Fargo raises Cardinal Health stock price target on pharma strength | ||
| ZIMMER BIOMET | 92,68 | 0,00 % | Zimmer Biomet upgraded at Wells Fargo on Monogram orthopedic robot | ||
| UNIDOC HEALTH | 0,028 | -7,95 % | CSE Bulletin: Reinstatement - UniDoc Health Corp. (UDOC) | Le 7 octobre/October 2026
Effective immediately, UniDoc Health Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
__________________________
En... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,128 | -22,11 % | Co-Diagnostics Announces Reverse Stock Split | SALT LAKE CITY, Nov. 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Diagnostics" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| CLARIANE | 3,324 | +0,42 % | Clariane: Signing of a new €700 million syndicated revolving credit facility maturing 2031 | 21 September 2026 Signing of a new €700 million revolving credit facility maturing in 2031 Paris, 21 September 2026: following the success of its €500 million senior bonds offering completed on 8 September... ► Artikel lesen | |
| PANGENOMIC HEALTH | 0,120 | +1,70 % | PanGenomic Health Inc.: PanGenomic Health Announces Exclusive Distributorship Agreement with Colombian Subsidiary of Ayla Bioscience and Expiration of Non-Binding Letter of Intent | ||
| INSPIREMD | 0,605 | +7,08 % | InspireMD Inc.: InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard Prime TransCarotid Stent System | ||
| VYOME | 1,430 | -1,38 % | Vyome Holdings, Inc. GAAP EPS of -$0.13 in-line, revenue of $0.06M | ||
| IZOTROPIC | 0,064 | 0,00 % | Izotropic Corporation: Izotropic Closes Non-Brokered Private Placement | Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - October 6, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device... ► Artikel lesen | |
| ASTRANA HEALTH | 26,400 | +0,76 % | Astrana Health, Inc. Reports Third Quarter 2026 Results | Company to Host Conference Call on Thursday, November 5, 2026, at 2:30 p.m. PT/5:30 p.m. ETReports record revenue of $1,023.6 million, up 7% year-over-year, net income of $20.3 million, up 1,782% year-over-year... ► Artikel lesen | |
| ORGANOGENESIS | 0,730 | 0,00 % | Johnson & Johnson, GSK und Co.: Warum der Wettlauf um Zelltherapie-Plattformen gerade erst beginnt | ||
| CROSSJECT | 1,302 | -1,21 % | CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure | Cash and cash equivalents of €12.3 million as of June 30, 2026, a 2.4-fold increase compared to December 31, 2025 (€5.1 million), following the €15 million capital increase completed in May. Shareholders'... ► Artikel lesen | |
| ORIOLA | 0,770 | -1,03 % | ORIOLA OYJ: Oriola's Board of Directors resolves not to distribute an additional dividend instalment | ||
| BAUSCH+LOMB | 17,800 | -4,81 % | Bausch + Lomb Post-Surgery Eye Pain Drug Misses Study Goal But Shows Early Relief |